Diastolic dysfunction in rheumatoid arthritis patients with low disease activity.
Cardiovascular disease
Diastolic dysfunction
Echocardiography
Rheumatoid arthritis
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
27
09
2018
accepted:
12
11
2018
revised:
04
11
2018
pubmed:
13
12
2018
medline:
13
7
2019
entrez:
13
12
2018
Statut:
ppublish
Résumé
Patients with rheumatoid arthritis (RA) are at increased risk for congestive heart failure (CHF) and left ventricular diastolic dysfunction (LVDD), as compared to the general population. High disease activity is to be associated with higher incidence of cardiovascular disease (CVD), CHF, and mortality in RA patients. LVDD is not anticipated in RA patients without CVD symptoms and may be underdiagnosed especially in those with low disease activity. The study group consisted of 70 RA patients (54 women, 16 men) with no CVD and 33 healthy controls, of comparable age. All RA patients had low disease activity (DAS28 ≤ 3.2) from 2 to 7 years. Laboratory and imaging assessments included metabolic, RA-related, and cardiovascular parameters. Echocardiographic and Doppler studies were conducted in patients and controls with assessment of ejection fraction (EF) and diastolic dysfunction (assessed as E/A ratio). The mean E/A ratio did not differ significantly between RA patients and healthy controls (1.08 (0.28) vs 0.99 (0.21), NS); comparable numbers of patients and controls had abnormal E/A (< 1.0) (26 (37.1%) vs 10 (30.3%), NS). Patients with decreased E/A were significantly older and had higher disease duration, activity, and presence of bone erosions than their RA counterparts with normal E/A. The mean EF was not significantly different in patients and controls. The prevalence of DD as expressed by E/A ratio in RA patients with continued low disease activity was not different from that of controls. Higher disease duration and severity may predispose to DD occurrence in patients with preserved EF.
Identifiants
pubmed: 30539352
doi: 10.1007/s10067-018-4369-7
pii: 10.1007/s10067-018-4369-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1131-1137Références
Rheumatology (Oxford). 2011 Aug;50(8):1505-12
pubmed: 21482544
Ann Rheum Dis. 2007 Jan;66(1):76-80
pubmed: 16818462
Mod Rheumatol. 2015 Jul;25(4):552-7
pubmed: 25529032
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Clin Rheumatol. 2006 May;25(3):294-9
pubmed: 16222411
Arthritis Care Res (Hoboken). 2011 May;63(5):729-34
pubmed: 21225672
Clin Rheumatol. 2018 Apr;37(4):909-916
pubmed: 29307093
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Int J Cardiol. 2018 Nov 1;270:253-259
pubmed: 30017519
Arthritis Care Res (Hoboken). 2013 Apr;65(4):534-43
pubmed: 23002032
Int J Rheum Dis. 2011 Feb;14(1):18-30
pubmed: 21303478
Rheumatol Int. 2008 Apr;28(6):513-9
pubmed: 17957370
J Rheumatol. 2015 Nov;42(11):2029-37
pubmed: 26373561
J Vasc Surg. 1993 Apr;17(4):719-25
pubmed: 8464091
Ann Rheum Dis. 2017 Oct;76(10):1693-1699
pubmed: 28606965
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Ann Rheum Dis. 2010 Sep;69(9):1665-70
pubmed: 20498217
J Rheumatol. 2000 Jan;27(1):261-3
pubmed: 10648051
Rheumatol Int. 2018 Jul;38(7):1207-1215
pubmed: 29774373
Ann Rheum Dis. 2010 Feb;69(2):325-31
pubmed: 19773290